Combined Metagenomic Viral Detection and Donor-Derived Cell-Free DNA Quantification in Plasma From Kidney Transplant Recipients

Keyphrases

• Kidney Transplant Recipients 100%
• Metagenomics 100%
• DNA Quantification 100%
• Viral Detection 100%
• Donor-derived Cell-free DNA 100%
• Immunosuppression 60%
• Metagenomic NGS 60%
• Quantitative PCR 40%
• Whole Genome Sequencing 40%
• Viral Pathogens 40%
• Early Detection 20%
• Patient Management 20%
• Proviral DNA 20%
• Clinical Diagnosis 20%
• Viral Etiology 20%
• Allograft Rejection 20%
• Plasma Samples 20%
• Cytomegalovirus 20%
• Epstein-Barr Virus 20%
• Sequence Method 20%
• Non-pathogenic 20%
• Positivity Rate 20%
• Simultaneous Monitoring 20%
• Pathogen Surveillance 20%
• Patient Monitoring 20%
• Cell-free DNA (cfDNA) 20%
• Quantification Detection 20%
• Linear Relationship 20%
• Comparable Accuracy 20%
• Opportunistic Infections 20%
• Sensitive Detection 20%
• PCR Detection 20%
• Simultaneous Quantification 20%
• Viral Quantitation 20%
• BK Polyomavirus (BKPyV) 20%
• Viral Assay 20%
• Assisted Assembly 20%
• Unbiased Sequencing 20%
• Torque Teno Virus 20%
• Anelloviridae 20%
• Detection of Viral Infections 20%
• Taxonomic Annotation 20%

Immunology and Microbiology

• Blood Plasma 100%
• Metagenomics 100%
• Infectious Agent 100%
• Virus Detection 100%
• Next Generation Sequencing 60%
• Immunosuppression 60%
• Real-Time Polymerase Chain Reaction 60%
• Whole Genome Sequencing 40%
• Transplant Rejection 20%
• Viral Disease 20%
• Cytomegalovirus 20%
• BK Virus 20%
• Torque Teno Virus 1 20%
• Anelloviridae 20%
• Opportunistic Infection 20%
• Epstein Barr Virus 20%
• DNA Virus 20%